Poly-L-Lactic Acid Injection for HIV-Associated Facial Lipoatrophy: Treatment Principles, Case Studies, and Literature Review | Zendy

L KATES | Zendy; Rebecca C. Fitzgerald | Zendy

Open Access

Poly-L-Lactic Acid Injection for HIV-Associated Facial Lipoatrophy: Treatment Principles, Case Studies, and Literature Review

Author(s) -

L KATES,

Rebecca C. Fitzgerald

Publication year - 2008

Publication title -

aesthetic surgery journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.528

H-Index - 58

eISSN - 1527-330X

pISSN - 1090-820X

DOI - 10.1016/j.asj.2008.06.005

Subject(s) - medicine , lipoatrophy , human immunodeficiency virus (hiv) , dermatology , antiretroviral therapy , medline , surgery , family medicine , viral load , biochemistry , chemistry

Most HIV-positive patients receiving highly active antiretroviral therapy develop facial lipoatrophy soon after commencing treatment. Attempts to correct lipoatrophy through autologous fat transfer or the use of temporary, semipermanent, or permanent fillers have achieved some benefits, but either do not have lasting effects, do not treat some areas effectively, or have other disadvantages.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research